VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 139 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $1,069,000 | -1.6% | 70,273 | +16.0% | 0.02% | +18.8% |
| Q3 2017 | $1,086,000 | +9.0% | 60,605 | +1.3% | 0.02% | 0.0% |
| Q3 2016 | $996,000 | +207.4% | 59,854 | +71.8% | 0.02% | +700.0% |
| Q4 2015 | $324,000 | -22.9% | 34,846 | -22.8% | 0.00% | -66.7% |
| Q1 2015 | $420,000 | -14.6% | 45,112 | +31.3% | 0.01% | 0.0% |
| Q4 2014 | $492,000 | -80.5% | 34,354 | -85.1% | 0.01% | -77.8% |
| Q3 2013 | $2,527,000 | – | 230,749 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 1,532,000 | $27,423,000 | 3.23% |
| Stonepine Capital Management, LLC | 300,000 | $5,370,000 | 3.16% |
| Palo Alto Investors LP | 4,155,670 | $74,386,000 | 3.13% |
| GREAT POINT PARTNERS LLC | 497,531 | $8,906,000 | 1.73% |
| Avoro Capital Advisors LLC | 988,270 | $17,690,000 | 1.37% |
| UNIVERSITY OF NOTRE DAME DU LAC | 157,781 | $2,824,000 | 0.79% |
| Birchview Capital, LP | 68,000 | $1,217,000 | 0.63% |
| Cheyne Capital Management (UK) LLP | 74,000 | $1,323,000 | 0.48% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 352,604 | $6,311,000 | 0.43% |
| 361 CAPITAL LLC | 119,554 | $2,140,000 | 0.41% |